Veraxa Biotech stock gains on FDA-aligned testing strategy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- S&P 500, Nasdaq retreat from record highs as yields and oil climb
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
- Musk rules out TSMC role in Terafab operations; Intel gains
| (NASDAQ: VRXA) | Delayed: 1.15 +0.07 (6.48%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.08 | 52 Week High | $ | |||
| Open | $1.16 | 52 Week Low | $ | |||
| Day High | $1.21 | P/E | N/A | |||
| Day Low | $1.10 | EPS | $ | |||
| Volume | 204,533 | |||||
